• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种高效、低成本的 T 淋巴细胞基因转移方法。

An efficient low cost method for gene transfer to T lymphocytes.

机构信息

Programa de Carcinogênese Molecular, Coordenação de Pesquisa (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.

出版信息

PLoS One. 2013;8(3):e60298. doi: 10.1371/journal.pone.0060298. Epub 2013 Mar 26.

DOI:10.1371/journal.pone.0060298
PMID:23555950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3608570/
Abstract

UNLABELLED

Gene transfer to T lymphocytes has historically relied on retro and lentivirus, but recently transposon-based gene transfer is rising as a simpler and straight forward approach to achieve stable transgene expression. Transfer of expression cassettes to T lymphocytes remains challenging, being based mainly on commercial kits.

AIMS

We herein report a convenient and affordable method based on in house made buffers, generic cuvettes and utilization of the widely available Lonza nucleofector II device to promote efficient gene transfer to T lymphocytes.

RESULTS

This approach renders high transgene expression levels in primary human T lymphocytes (mean 45%, 41-59%), the hard to transfect murine T cells (mean 38%, 36-42% for C57/BL6 strain) and human Jurkat T cell line. Cell viability levels after electroporation allowed further manipulations such as in vitro expansion and Chimeric Antigen Receptor (CAR) mediated gain of function for target cell lysis.

CONCLUSIONS

We describe here an efficient general protocol for electroporation based modification of T lymphocytes. By opening access to this protocol, we expect that efficient gene transfer to T lymphocytes, for transient or stable expression, may be achieved by an increased number of laboratories at lower and affordable costs.

摘要

未加标签

基因转移到 T 淋巴细胞在历史上依赖于逆转录病毒和慢病毒,但最近基于转座子的基因转移作为一种更简单、更直接的方法来实现稳定的转基因表达而兴起。T 淋巴细胞的表达盒转移仍然具有挑战性,主要基于商业试剂盒。

目的

我们在此报告一种基于自制缓冲液、通用比色皿和广泛使用的 Lonza 电穿孔仪 II 装置的便捷且经济实惠的方法,以促进 T 淋巴细胞的有效基因转移。

结果

该方法在原代人 T 淋巴细胞(平均 45%,41-59%)、难转染的小鼠 T 细胞(C57/BL6 品系平均 38%,36-42%)和人 Jurkat T 细胞系中产生高水平的转基因表达。电穿孔后的细胞活力水平允许进一步进行操作,如体外扩增和嵌合抗原受体(CAR)介导的靶细胞裂解的功能获得。

结论

我们在这里描述了一种用于 T 淋巴细胞电穿孔修饰的有效通用方案。通过开放对该方案的访问,我们期望更多的实验室能够以更低的成本实现高效的 T 淋巴细胞基因转移,无论是瞬时表达还是稳定表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/7d8237b54b62/pone.0060298.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/ecf00f1c6a9a/pone.0060298.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/78ec4ca4c6ab/pone.0060298.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/4a4d95109d0e/pone.0060298.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/e8ca6d97675b/pone.0060298.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/d6b32b6388d6/pone.0060298.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/3bfa311526c2/pone.0060298.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/94cc5b9cdf94/pone.0060298.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/7d8237b54b62/pone.0060298.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/ecf00f1c6a9a/pone.0060298.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/78ec4ca4c6ab/pone.0060298.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/4a4d95109d0e/pone.0060298.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/e8ca6d97675b/pone.0060298.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/d6b32b6388d6/pone.0060298.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/3bfa311526c2/pone.0060298.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/94cc5b9cdf94/pone.0060298.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f846/3608570/7d8237b54b62/pone.0060298.g008.jpg

相似文献

1
An efficient low cost method for gene transfer to T lymphocytes.一种高效、低成本的 T 淋巴细胞基因转移方法。
PLoS One. 2013;8(3):e60298. doi: 10.1371/journal.pone.0060298. Epub 2013 Mar 26.
2
Generation of CAR+ T Lymphocytes Using the Sleeping Beauty Transposon System.利用睡美人转座子系统生成CAR+ T淋巴细胞
Methods Mol Biol. 2020;2086:131-137. doi: 10.1007/978-1-0716-0146-4_9.
3
Minicircles for CAR T Cell Production by Sleeping Beauty Transposition: A Technological Overview.基于睡美人转座子的 CAR T 细胞生产用微小环:技术概述。
Methods Mol Biol. 2022;2521:25-39. doi: 10.1007/978-1-0716-2441-8_2.
4
An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells.一种用于哺乳动物细胞基因改造的高效电穿孔方案。
Front Bioeng Biotechnol. 2017 Jan 23;4:99. doi: 10.3389/fbioe.2016.00099. eCollection 2016.
5
High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation.使用RNA电穿孔法对原代人源和鼠源T淋巴细胞进行高效转染。
Mol Ther. 2006 Jan;13(1):151-9. doi: 10.1016/j.ymthe.2005.07.688. Epub 2005 Sep 2.
6
CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In Vitro and In Vivo.使用睡眠美人转座子载体生成的 CAR T 细胞,并通过 EBV 转化的淋巴母细胞系扩增,在体外和体内显示出抗肿瘤活性。
Hum Gene Ther. 2019 Apr;30(4):511-522. doi: 10.1089/hum.2018.218.
7
Comparison of lentiviral and sleeping beauty mediated αβ T cell receptor gene transfer.慢病毒和睡眠美丽介导的αβ T 细胞受体基因转移的比较。
PLoS One. 2013 Jun 28;8(6):e68201. doi: 10.1371/journal.pone.0068201. Print 2013.
8
High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression.通过结合32℃离心和CH-296包被板将高效基因转移到恒河猴原代T淋巴细胞中:基因转移方案对T细胞归巢受体表达的影响。
Hum Gene Ther. 2001 Oct 10;12(15):1843-55. doi: 10.1089/104303401753153901.
9
Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.利用piggyBac基因转移技术和患者来源材料低成本生产符合药品生产质量管理规范级别的表达CD19特异性嵌合抗原受体的T细胞。
Cytotherapy. 2015 Sep;17(9):1251-67. doi: 10.1016/j.jcyt.2015.05.013. Epub 2015 Jul 23.
10
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.多次注射表达嵌合抗原受体的电穿孔自体 T 细胞可介导人转移性肿瘤消退。
Cancer Res. 2010 Nov 15;70(22):9053-61. doi: 10.1158/0008-5472.CAN-10-2880. Epub 2010 Oct 5.

引用本文的文献

1
Enhancing the Efficacy of CAR-T Cell Production Using BX795 and Rosuvastatin in a Serum-Free Medium.在无血清培养基中使用BX795和瑞舒伐他汀提高CAR-T细胞生产效率
Int J Mol Sci. 2025 Mar 25;26(7):2988. doi: 10.3390/ijms26072988.
2
All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone.一体化CRISPR/Cas基因工程改造的糖皮质激素受体敲除、EBV-gp350嵌合抗原受体敲入T细胞效力强大且对地塞米松具有抗性。
Exp Hematol Oncol. 2025 Mar 19;14(1):40. doi: 10.1186/s40164-025-00631-w.
3
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells.

本文引用的文献

1
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood.睡美人转座子系统及人工抗原呈递细胞在对来自外周血和脐带血的T细胞进行基因改造中的临床应用
J Vis Exp. 2013 Feb 1(72):e50070. doi: 10.3791/50070.
2
Will T-cell therapy for cancer ever be a standard of care?癌症的 T 细胞疗法会成为标准治疗方法吗?
Cancer Gene Ther. 2012 Dec;19(12):818-21. doi: 10.1038/cgt.2012.74. Epub 2012 Oct 12.
3
Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.
通过微流体涡旋脱落实现的可扩展细胞内递送增强了嵌合抗原受体T细胞的功能。
Sci Rep. 2025 Feb 17;15(1):5749. doi: 10.1038/s41598-025-89070-5.
4
Enhancement effect of urea toward electroporation-mediated plasmid transfection efficiency in the HEK-293 cell line.尿素对人胚肾细胞系(HEK-293)中电穿孔介导的质粒转染效率的增强作用。
Res Pharm Sci. 2024 Dec 15;19(6):766-773. doi: 10.4103/RPS.RPS_185_23. eCollection 2024 Dec.
5
An artificial transcription factor that activates potent interferon-γ expression in human Jurkat T Cells.一种能在人Jurkat T细胞中激活强效γ干扰素表达的人工转录因子。
Front Mol Med. 2025 Jan 8;4:1492370. doi: 10.3389/fmmed.2024.1492370. eCollection 2024.
6
Making gene editing accessible in resource limited environments: recommendations to guide a first-time user.在资源有限的环境中实现基因编辑的可及性:指导初次使用者的建议
Front Genome Ed. 2024 Sep 25;6:1464531. doi: 10.3389/fgeed.2024.1464531. eCollection 2024.
7
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells.通过微流体涡旋脱落实现的可扩展细胞内递送增强了嵌合抗原受体T细胞的功能。
Res Sq. 2024 Sep 19:rs.3.rs-4870379. doi: 10.21203/rs.3.rs-4870379/v1.
8
Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity.肿瘤微环境中的氯化钠增强了 T 细胞的代谢适应性和细胞毒性。
Nat Immunol. 2024 Oct;25(10):1830-1844. doi: 10.1038/s41590-024-01918-6. Epub 2024 Aug 28.
9
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo.一个可递送单链和双链 Cas9/guide RNA 以在体外和体内干扰基因的平台。
Mol Ther. 2024 Oct 2;32(10):3629-3649. doi: 10.1016/j.ymthe.2024.07.025. Epub 2024 Jul 31.
10
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells.通过微流体涡旋脱落实现的可扩展细胞内递送增强了嵌合抗原受体T细胞的功能。
bioRxiv. 2024 Jul 13:2024.06.25.600671. doi: 10.1101/2024.06.25.600671.
抑制细胞内抗病毒防御机制可增强慢病毒对人自然杀伤细胞的转导:对基因治疗的影响。
Hum Gene Ther. 2012 Oct;23(10):1090-100. doi: 10.1089/hum.2012.080. Epub 2012 Sep 10.
4
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.逆转录病毒修饰的嵌合抗原受体 T 细胞的十年安全性和功能。
Sci Transl Med. 2012 May 2;4(132):132ra53. doi: 10.1126/scitranslmed.3003761.
5
Adoptive immunotherapy for cancer: harnessing the T cell response.癌症的过继免疫疗法:利用 T 细胞应答。
Nat Rev Immunol. 2012 Mar 22;12(4):269-81. doi: 10.1038/nri3191.
6
Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.通过慢病毒转导或 mRNA 转染表达的嵌合 NKG2D 受体将 T 细胞重定向至尤文氏肉瘤家族肿瘤。
PLoS One. 2012;7(2):e31210. doi: 10.1371/journal.pone.0031210. Epub 2012 Feb 15.
7
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.输注 CD19 靶向 T 细胞以增强接受自体造血干细胞移植治疗晚期 B 淋巴细胞恶性肿瘤患者的疾病控制。
Hum Gene Ther. 2012 May;23(5):444-50. doi: 10.1089/hum.2011.167. Epub 2012 Jan 17.
8
Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.嵌合抗原受体在肿瘤免疫基因治疗中的应用:现状与未来方向。
Int Rev Immunol. 2011 Oct-Dec;30(5-6):294-311. doi: 10.3109/08830185.2011.595855.
9
Inducible apoptosis as a safety switch for adoptive cell therapy.诱导细胞凋亡作为过继细胞治疗的安全开关。
N Engl J Med. 2011 Nov 3;365(18):1673-83. doi: 10.1056/NEJMoa1106152.
10
Plasmid DNA gene therapy by electroporation: principles and recent advances.电穿孔法进行质粒 DNA 基因治疗:原理与最新进展。
Curr Gene Ther. 2011 Dec;11(6):447-56. doi: 10.2174/156652311798192860.